Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions

Reuters

05-24

Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions

Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2537163348"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537163348\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2537163348?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-24 07:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537163348","market":"nz","top_or_hot":-1,"title":"Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAchieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-24 07:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACHV","symbol_name":"Achieve Life Sciences, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL9dfVhl:1","article_id":"2537163348","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537163348","pubTimestamp":1748044795,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application  for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACHV":"Achieve Life Sciences, Inc.","BK4139":"生物科技"},"translate_title":"Achieve Life Sciences Inc.推出关于通过戒烟解决方案改变公共卫生的演讲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACHV":0.9},"content_text":"Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n    \n\n        Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}